Target type: molecularfunction
Binding to a nuclear localization sequence, a specific peptide sequence that acts as a signal to localize the protein within the nucleus. [GOC:ai]
Nuclear localization sequences (NLSs) are short stretches of amino acids that act as signal sequences for proteins to be transported into the nucleus. These sequences are recognized by importin proteins, a family of nuclear transport receptors. Importins bind to NLSs and facilitate the movement of their cargo proteins through the nuclear pore complex (NPC), a large protein channel that regulates transport between the cytoplasm and the nucleus.
The binding of an importin to an NLS is a complex process that involves several steps. First, the importin binds to the NLS in the cytoplasm. Then, the importin-NLS complex associates with the NPC. Once inside the nucleus, the cargo protein is released from the importin, and the importin is recycled back to the cytoplasm.
The molecular function of NLS binding can be described as a protein-protein interaction that triggers the nuclear import of proteins. This process is essential for a variety of cellular functions, including gene expression, DNA replication, and cell division.
NLS binding is a highly specific process. Different NLSs can bind to different importin proteins, and different importin proteins can transport different cargo proteins. This specificity ensures that only the correct proteins are imported into the nucleus.
In summary, NLS binding is a key step in the nuclear import pathway. It is a highly regulated process that ensures the proper localization of proteins within the cell. It is crucial for various cellular processes and is essential for maintaining the integrity of the nucleus and the proper functioning of the cell.'
"
Protein | Definition | Taxonomy |
---|---|---|
NF-kappa-B inhibitor alpha | An NF-kappa-B inhibitor alpha that is encoded in the genome of human. [TLR:AMM, UniProtKB:P25963] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
8-(4-benzenesulfonylamino)quinoline | 8-(4-benzenesulfonylamino)quinoline: has diabetogenic properties; structure given in first source | ||
benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde: proteasome inhibitor N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal : A tripeptide that is L-leucyl-L-leucyl-L-leucine in which the C-terminal carboxy group has been reduced to the corresponding aldehyde and the N-terminal amino group is protected as its benzyloxycarbonyl derivative. | amino aldehyde; carbamate ester; tripeptide | proteasome inhibitor |
5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide | benzothiazine | ||
nsc-287088 | |||
physalin a | physalin A: an anti-inflammatory agent isolated from Physalis alkekengi var; structure in first source | physalin | |
physalin f | physalin F : A physalin with antimalarial and antitumour activities isolated from Physalis angulata. physalin F: has immunosuppressive activity; from Physalis angulata L; structure given in first source | enone; epoxy steroid; lactone; physalin | antileishmanial agent; antimalarial; antineoplastic agent; apoptosis inducer; immunosuppressive agent |